CompletedPhase 2NCT04768166

Testing Miglustat Administration in Subjects With Spastic Paraplegia 11

Studying Pure or complex autosomal dominant spastic paraplegia

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: IRCCS Fondazione Stella Maris
Principal Investigator: Filippo M Santorelli, MD PhD
IRCCS Stella Maris
Intervention: Miglustat 100 MG(drug)
Enrollment: 10 enrolled
Eligibility: 14 years · All sexes
Timeline: 2021 – 2021

Study locations (1)

IRCCS Fondazione Stella Maris, Pisa, PI, Italy

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04768166 on ClinicalTrials.gov

← Back to all trials